Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
about
Regulatory cells and transplantation toleranceMedawar's legacy to cellular immunology and clinical transplantation: a commentary on Billingham, Brent and Medawar (1956) 'Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance'Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies."Infectious" transplantation tolerance.Reprogramming the immune system.Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells.The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected].Hybrid antibody mediated veto of cytotoxic T lymphocyte responses.Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy.Conditions that induce tolerance in mature CD4+ T cellsTransforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.Immune privilege induced by regulatory T cells in transplantation tolerance.Bilateral hyphaema following diode laser for retinopathy of prematurity.Celiac disease: the search for adjunctive or alternative therapies.Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.Suppression of induction of experimental immune mediated blepharoconjunctivitis by tolerogenic conjugates of the antigen and monomethoxypolyethylene glycol.Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro.Tolerogenicity of donor major histocompatibility complex-matched skin grafts in previously tolerant Massachusetts general hospital miniature swine.Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.Regulatory T cells and transplantation tolerance.Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti-CD4 monoclonal antibodies.Antagonism of cytotoxic T-lymphocyte activation by soluble CD8.Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.Long-term survival of hamster islet xenografts in mice under short-course treatment with nondepleting versus depleting anti-CD4 monoclonal antibodies.CD4+ T Cell Fate Decisions Are Stochastic, Precede Cell Division, Depend on GITR Co-Stimulation, and Are Associated With Uropodium Development.
P2860
Q26865816-FF07C212-3C62-4265-8FC1-1109B9FBB3A2Q27027102-45F38DCE-7939-43C9-A989-3AD8230CA59CQ28351153-543A7FC1-20BD-48BE-9FE0-29C380EE5D15Q33760317-72F8EB9D-9A03-4D35-95A8-8CBD940A65A4Q34321820-B5B86BE1-207E-444C-A957-1F5D2999B419Q34726892-EE0D95C6-25BD-430D-A87B-3E000A1A6A27Q34792489-AF0E28AE-42AA-4B90-B0AE-9159A598D2CCQ35949649-C8762EF6-85D3-445B-9A53-EBFFA7B8F7BDQ36362485-199F7154-3A64-43C6-A6E4-BB32368381B5Q36366611-D26E3FED-9D88-4EA7-86DD-24862FC3F8A2Q36367885-B614EF6E-C113-4DBE-B193-1EDD6B45D56DQ36376510-1A3CA101-EF33-465B-926A-7954B591FC72Q36563528-1D3E5615-2104-43C7-B6B3-1B4E1C2146F1Q36593774-DECA6047-C3E3-4CC1-9180-AAF9FA71ED2AQ36787917-3ADDE066-ABB9-4707-84B0-9B249955CB5CQ38184586-06329955-CFFF-4C7B-9307-6CA7B0FBE8EBQ39452477-03DEEDC4-7854-4422-B0F7-B618D6C48824Q39706642-D7DFF7C7-0086-4DB7-9D95-7CBB9EF8B91BQ39713867-F0784175-EAFA-4FD0-AA7C-37F972C29489Q39723711-FD38BBE2-5B93-4AB7-B9E5-EADB983ED8FCQ41807328-98B19F45-0996-460B-9059-B7F4E9549E88Q42000010-EA13D0BB-053F-47C5-9A95-E7D7BE45E330Q42276578-5C894F29-3159-49D5-8D73-56A34FE0CC1DQ42676935-9736FC67-E97C-4AF8-A420-C3F27B61012DQ43563597-B70D9911-C47B-45D8-B18F-C622FA2ABB37Q47240621-9228C177-649C-423C-9E48-37598299A249Q48559674-079FECA9-D813-431B-9693-852B5DB1156BQ52534683-4BC9B873-2BB6-46DB-8F01-FC014CF1FE3AQ54029734-ACA7D631-999B-4213-AC6B-0E28037DCC74Q54113448-E3F00C67-2955-4C28-AC18-C91D38A139BEQ55411821-9F070D6D-A386-4D21-9FE0-11F6D91A1FC8
P2860
Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@ast
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@en
type
label
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@ast
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@en
prefLabel
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@ast
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@en
P2093
P2860
P1476
Reprogramming the immune syste ...... and CD8 monoclonal antibodies.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1992.TB01423.X
P577
1992-10-01T00:00:00Z